Back to dashboard
MedicaidCoverageHigh impact

Newsletter Vol. 4, No. 18

New Jersey Medicaid·NJ · Pharmacy·Provider Notice
Effective date
Not stated
We identified it
Jun 20, 2026
Days to comply
—

Summary

New Jersey Medicaid has added 6 pharmaceutical manufacturers to its rebate program (now eligible for reimbursement) and deleted 8 manufacturers (no longer reimbursed effective immediately). Billing teams must update their pharmacy claim systems to verify manufacturer eligibility before submitting claims, as drugs from deleted manufacturers will be denied by Medicaid.

Action Required

Action needed
Immediately: Billing team and pharmacy staff must update claim submission systems to cross-reference manufacturer labeler codes against the approved list. ADDITIONS (now approved): Suppositoria Laboratories, Hillestrad International Inc, Ferring Laboratories Inc, Commons Brothers Inc, Benchmark Enterprises Inc, SoloPak Medical Products Inc. DELETIONS (no longer reimbursed): Lannett Company Inc, Chemrich Laboratories Inc, Syosset Laboratories Inc, Lyphomed Novopharm Pharmaceuticals, Novopharm Incorporated, Grupak Laboratories Inc, Choice Drug Systems of Maryland, RA Pharmaceuticals. Before dispensing or billing, verify manufacturer participation status in the New Jersey Medicaid rebate program. Claims submitted for drugs from deleted manufacturers will be DENIED and may result in liability to the pharmacy or practice. Retain this newsletter in the provider reference materials and disseminate to all pharmacy and billing staff.

Related policy hubs